The place of the botulinum toxin in the management of multiple sclerosis

Keyphrases

• Multiple Sclerosis 100%
• Botulinum Neurotoxin (BoNT) 100%
• Multiple Sclerosis Treatment 66%
• Spasticity 66%
• Adductor 66%
• Quality of Life 33%
• Gastroparesis 33%
• Effective Treatment 33%
• Older Adults 33%
• Quality of Life Improvement 33%
• Treatment Options 33%
• General Quality of Life 33%
• Tremor 33%
• Activities of Daily Living 33%
• Thigh 33%
• Chronic Disease 33%
• Daily Functioning 33%
• Nervous System Diseases 33%
• Incontinence 33%
• Shoulder Joint 33%
• Botulinum Toxin Injection 33%
• Neuro-ophthalmology 33%
• Trigeminal Neuralgia 33%
• Workability 33%
• Overreactivity 33%
• Urinary Urgency 33%
• Bladder Pain Syndrome 33%
• Nocturia 33%
• Detrusor 33%
• Ophthalmic Complications 33%
• Sustained Improvement 33%
• Sialorrhea 33%
• Facial Myokymia 33%
• Facial Hyperhidrosis 33%
• Pes Equinus 33%
• Striatal Toe 33%

Medicine and Dentistry

• Multiple Sclerosis 100%
• Clostridium Botulinum Type A 100%
• Quality of Life 60%
• Botulinum Toxin A 60%
• Spasticity 40%
• Stomach Paresis 20%
• Chronic Disease 20%
• Central Nervous System 20%
• Work Capacity 20%
• Trigeminal Neuralgia 20%
• Toe 20%
• Hypersalivation 20%
• Incontinence 20%
• Urinary Urgency 20%
• Bladder Dysfunction 20%
• Nocturia 20%
• Detrusor 20%
• Hyperhidrosis 20%
• Myokymia 20%
• Shoulder Joint 20%
• Pes equinus 20%
• Thigh 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Sclerosis 100%
• Clostridium Botulinum Type A 100%
• Botulinum Toxin A 60%
• Spasticity 40%
• Stomach Paresis 20%
• Chronic Disease 20%
• Incontinence 20%
• Trigeminus Neuralgia 20%
• Hypersalivation 20%
• Nocturia 20%
• Bladder Dysfunction 20%
• Hyperhidrosis 20%
• Urinary Urgency 20%
• Pes equinus 20%
• Myokymia 20%